Search This Blog

Friday, November 25, 2022

Oppenheimer Adjusts Cognition Therapeutics Price Target to $9 From $18

Maintains Outperform Rating 

https://www.marketscreener.com/quote/stock/COGNITION-THERAPEUTICS-I-127926318/news/Oppenheimer-Adjusts-Cognition-Therapeutics-Price-Target-to-9-From-18-Maintains-Outperform-Rating-42322388/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.